Treatment of sexual dysfunction with N-hydroxyguanidine compounds
US6277884A · kind A · utility
34Cited by
2References
16Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 28, 1999 |
| Grant date | Aug 21, 2001 |
| Priority date | — |
| Expiry date | May 28, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods of treating sexual dysfunctions in patients by administering at least one N-hydroxyguanidine compound that is a substrate for nitric oxide synthase, and, optionally, one or more vasoactive agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.